New York Mercantile Exchange › RBOB GASOLINE Nov 2014/Feb 2015 Spread (NYMEX:RB.X14_G15.E)
0.0076 0.0000 (0.00%)
2013-05-21 17:42:37, 30 min delay
| Last Price | 0.0076 |
|---|---|
| Open | 0.0076 |
| High | 0.0076 |
| Time | 2013-05-21 17:42:37 |
| Contract High Date | 2013-05-20 |
| Contract Low Date | 2013-04-02 |
| Close Time | 14:30 |
| Settle Time | 17:43 |
|---|---|
| Previous Close | 0.0076 |
| Low | 0.0076 |
| Contract High | 0.0086 |
| Contract Low | -0.0015 |
| Open Time | 09:00 |
Free Instant Analysis: Let our Trade Triangle technology, brought to you courtesy of our premium service MarketClub, instantly analyze any stock, futures or forex market for you. It’s free, It’s informative, It’s on the money.
Trader's Blog
Today's Video Update: Target And Lowe's Both Miss... Who's Next?
6 hours ago
Is Wal-Mart the "Canary in the Mine"?
11 hours ago
Poll: What do you think of U.S. taxes?
1 day ago
Supercharge Your Portfolio With These Powerful ETFs
1 day ago
Today's News
How the Dow Jones industrial average fared
2 hours, 55 minutes ago
Stock indexes fell on Wall Street on fear the Federal Reserve could pull back from its stimulus programs soon. After surging early in the day, stocks fell as investors digested minutes of a Fed meeting that suggested the stimulus could be scaled back as early as next month if the economy picks up. The Dow Jones industrial average fell 80.41 points, or 0.5 percent, to close at 15,307.17.
AP Top Extended Financial Headlines At 5:46 p.m. EDT
2 hours, 51 minutes ago
Stocks fall, interest rates rise after Fed minutes show policymakers weighed stimulus pullback Fed appears divided over when to slow bond purchases; some would consider a pullback soon
AP Top Financial News At 5:46 p.m. EDT
2 hours, 53 minutes ago
Stocks fall on news Fed weighed cutting stimulus Median CEO pay rises to $9.7 million in 2012 A divided Fed wrestles with when to slow bond buys
FDA panel backs experimental Merck insomnia drug
2 hours, 57 minutes ago
A federal panel of medical experts said that an experimental insomnia drug from Merck & Co. Inc. appears safe and effective, despite evidence from company trials that the pill can cause daytime sleepiness and difficulty driving. The FDA is not required to follow the recommendations of its experts, though it often does.
